Daniela Sydoruk

发表

The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity

Isabelle H. Osuch, Phillipa Bartlett, G. Kochan, 2021, British Journal of Cancer.